Core Insights - Silicon Laboratories, Inc. reported first-quarter revenues of $178 million, exceeding market expectations, with significant growth in both Industrial & Commercial and Home & Life segments [1] - The company reaffirmed its full-year outlook, projecting FY25 revenue of $785 million, with analysts anticipating upward revisions to consensus estimates following positive results [2][3] Financial Performance - Industrial & Commercial revenue reached $96 million, a 47% year-over-year increase, while Home & Life revenue was $82 million, reflecting a 99% year-over-year growth [1] - Analysts project mid-single-digit quarter-over-quarter growth for the third and fourth quarters, estimating sales of $203 million and $216 million respectively [2] Analyst Expectations - Benchmark analyst Cody Acree expects modest upward revisions to consensus estimates and maintains a Buy rating with a price target of $160 [5] - Needham analyst N. Quinn Bolton also reiterated a Buy rating, projecting a price target of $150 and forecasting over 20% year-over-year revenue growth for FY25, with a more aggressive estimate of 33% growth [3][5] Market Trends - The company’s end markets are recovering from cyclical downturns, with inventory levels returning to typical ranges, indicating a positive trend in customer and channel inventory management [2][4] - Growth in the second half of FY25 is expected to be driven by design wins in smart metering, continuous glucose monitors, and electronic shelf labels [4]